Metabolic characterization of ILCs under homeostatic or stress conditions.
Innate lymphoid cells (ILCs) are the most recently identified components of the innate immune system. ILCs colonize mainly mucosa-associated tissues and they have a crucial role in metabolic homeostasis, and defense against infect...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
ILCADAPT
Innate lymphoid cells and tissue adaptation to changing meta...
2M€
Cerrado
ILC_REACTIVITY
Biological Determinants of ILC Reactivity for Immune Respons...
2M€
Cerrado
PID2021-125415OB-I00
CELULAS DENDRITICAS CONVENCIONALES DE TIPO 1, GUARDIANAS Y R...
399K€
Cerrado
ILCHI
Innate lymphoid cells in intestinal homeostasis and immunity
194K€
Cerrado
RTI2018-099114-B-I00
EL SISTEMA INMUNITARIO PULMONAR EN HOMEOSTASIS E INFECCION:...
218K€
Cerrado
Información proyecto ILMET
Duración del proyecto: 28 meses
Fecha Inicio: 2017-04-04
Fecha Fin: 2019-08-31
Líder del proyecto
INSTITUT PASTEUR
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
173K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Innate lymphoid cells (ILCs) are the most recently identified components of the innate immune system. ILCs colonize mainly mucosa-associated tissues and they have a crucial role in metabolic homeostasis, and defense against infections and cancer. ILCs are highly plastic and they rapidly shape their functional output in response to local environmental cues. Two ILC subsets (ILC2 and NK cells) have been respectively implicated in the maintenance of adipose tissue homeostasis and in the development of chronic inflammation in obese patients. It has been shown that cellular metabolism affects the development and function of adaptive lymphocytes. In contrast, very little is known about innate lymphocytes metabolic requirements under homeostatic conditions and how they metabolically adapt to environmental perturbations.
This project will study metabolic profiles in human ILC subsets isolated from the bloodstream, lymphoid and non-lymphoid tissues under healthy conditions and inflammatory disease states. Whole-genome transcriptomes, proteomes and metabolomes will be compared in order to decipher the pathways that regulate ILCs. A better understanding of the metabolic network that govern ILCs in steady state and how these cells switch their metabolism to exert their function, may ultimately reveal novel targets for the treatment of chronic inflammatory diseases and metabolic disorders, like obesity.